Currently holds positions in Eyenovia Inc, Soleno Therapeutics Inc and Kindred Biosciences Inc
Position | Company | Period |
---|---|---|
Director | Eyenovia Inc | None - |
Independent Chairman of the Board | Soleno Therapeutics Inc | Feb. 1, 2014 - |
Independent Director | Kindred Biosciences Inc | April 2, 2018 - |
Independent Director | Celgene Corp | Aug. 22, 2007 - Nov. 20, 2019 |
Independent Director | Tonix Pharmaceuticals Holding Corp | Oct. 14, 2011 - Sept. 5, 2018 |
Independent Chairman of the Board | Chimerix Inc | Feb. 1, 2013 - June 1, 2018 |
Independent Director | Kindred Biosciences Inc | Feb. 15, 2013 - May 23, 2016 |
Independent Director | Boston Scientific Corp | Oct. 30, 2001 - April 15, 2016 |
Lead Independent Director | Pharmaceutical Product Development Inc | July 1, 2009 - Jan. 1, 2016 |
Director | XenoPort Inc | June 15, 2012 - May 19, 2015 |
Chairman & CEO | Soleno Therapeutics Inc | Aug. 1, 2007 - Feb. 1, 2014 |
Independent Director | Maxygen Inc | July 20, 2001 - Aug. 29, 2013 |
Independent Director | Vivus Inc | April 18, 2012 - July 19, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-04-04 | 2022-03-31 |
Soleno Therapeutics Inc
(SLNO)
|
B Purchase |
930,000
0.000 USD |
930,000 | 0.00 | 0 USD | |
2022-04-04 | 2022-03-31 |
Soleno Therapeutics Inc
(SLNO)
|
B Purchase |
930,000
0.000 USD |
930,000 | 0.00 | 0 USD | |
2020-03-26 | 2020-03-24 |
Eyenovia Inc
(EYEN)
|
B Purchase |
82,431
+33.7%
2.27187,118 USD |
82,431 +33.7% | 2.27 | 187,118 USD | |
2019-07-15 | 2019-07-11 |
Eyenovia Inc
(EYEN)
|
B Purchase |
35,971
+15.2%
2.7899,999 USD |
35,971 +15.2% | 2.78 | 99,999 USD | |
2019-02-14 | 2019-02-12 |
Celgene Corp
(CELG)
|
B Purchase |
2,000
+inf%
89.99179,980 USD |
2,000 +inf% | 89.99 | 179,980 USD | |
2019-05-21 | 2018-01-29 |
Eyenovia Inc
(EYEN)
|
B Purchase |
90,000
+61.3%
10.00900,000 USD |
90,000 +61.3% | 10.00 | 900,000 USD | |
2016-12-29 | 2016-12-27 |
Chimerix Inc
(CMRX)
|
PS Planned sale |
72,073
-19.6%
4.68337,143 USD |
72,073 -19.6% | 4.68 | 337,143 USD | |
2016-08-19 | 2016-08-18 |
Soleno Therapeutics Inc
(SLNO)
|
B Purchase |
25,000
+1.4%
0.9924,750 USD |
25,000 +1.4% | 0.99 | 24,750 USD | |
2016-05-23 | 2016-05-20 |
Soleno Therapeutics Inc
(SLNO)
|
B Purchase |
5,637
+0.3%
1.206,764 USD |
5,637 +0.3% | 1.20 | 6,764 USD | |
2015-08-25 | 2015-08-21 |
Soleno Therapeutics Inc
(SLNO)
|
B Purchase |
16,228
+1.1%
1.9130,995 USD |
16,228 +1.1% | 1.91 | 30,995 USD | |
2015-08-12 | 2015-08-11 |
Soleno Therapeutics Inc
(SLNO)
|
B Purchase |
50,000
+3.9%
1.7788,500 USD |
50,000 +3.9% | 1.77 | 88,500 USD | |
2004-05-05 | 2004-05-05 |
Ardea Biosciences Inc
(RDEA)
|
B Purchase |
20,000
+39.7%
13.00260,000 USD |
20,000 +39.7% | 13.00 | 260,000 USD | |
2004-05-06 | 2004-05-04 |
Boston Scientific Corp
(BSX)
|
B Purchase |
500
+0.5%
39.8619,930 USD |
500 +0.5% | 39.86 | 19,930 USD | |
2004-05-06 | 2004-05-04 |
Boston Scientific Corp
(BSX)
|
B Purchase |
2,200
+2.1%
39.8587,670 USD |
2,200 +2.1% | 39.85 | 87,670 USD |